Rs2740574

From SNPedia

Jump to: navigation, search
is asnp
is mentioned by
dbSNPrs2740574
hapmaprs2740574
hgdprs2740574
ensemblrs2740574
gopubmedrs2740574
scholarrs2740574
googlers2740574
pharmgkbrs2740574
hgvbaseg2prs2740574
medrefsnprs2740574
23andMers2740574
SNP Nexus

GeneCYP3A4
Chromosome7
Orientationminus
Position99220031
GenotypeEffect
rs2740574(A;A)normal
rs2740574(A;G)carrier of one CYP3A4*1B allele
rs2740574(G;G)2.5x increased risk for prostate or ovarian cancer; CYP3A4*1B homozygote


Genotypes Magnitude Summary
Rs2740574(A;A) 00 normal
Rs2740574(A;G) carrier of one CYP3A4*1B allele
Rs2740574(G;G) 22 2.5x increased risk for prostate or ovarian cancer; CYP3A4*1B homozygote

The rs2740574(G) allele encodes a variant form of CYP3A4 known as CYP3A4*1B.

rs2740574(G) alleles are associated with an ~10 fold higher risk of aggressive prostate cancer in African American males. [PMID 16414488, OMIM [1]]

A pooled study (1,400+ samples) along with a replication study conducted by members of the Ovarian Cancer Association Consortium found a 2.5-2.8x increased risk for ovarian cancer for rs2740574(G;G) individuals (CI: 1.2-6.5, p=0.017). The authors note that CYP3A4 encodes a key enzyme in estrogen metabolism and which may be linked to ovarian carcinogenesis.[PMID 19127255]

? (A;A) (A;G) (G;G)


[PMID 19921206] Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample

PharmGKBPA161145181
NameCYP3A4:-392A>G, CYP3A4*1B
AnnotationDefining variant for CYP3A4*1B; well studied, conflicting results on effect on gene transcription, no clear consensus on its significance for drug disposition, may be assocated with an increased risk of developing endometrial cancer after tamoxifen treatment.
GeneCYP3A4, CYP3A
FeatueIntron, Intron
EvidenceWeb Resource:http://www.pharmgkb.org/search/annotatedGene/cyp3a4/variant.jsp
Drugstamoxifen
DiseasesEndometrial Neoplasms
Curation LevelIn-Depth